Neurocrine(NBIX) - 2020 Q4 - Earnings Call Presentation

Neurocrine® Advancing Life-Changing Discoveries in Neuroscience neurocrine.com Q4 2020 / Year-End Corporate Presentation February 4, 2021 Nasdaq: NBIX Safe Harbor Statement and Non-GAAP Financial Measures In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: the benefits to be derived from our products and product candidates; the value our products and/o ...